Literature DB >> 23239515

Hypertrophic cardiomyopathy: how far should we go with genetic testing?

Jill A Fahrner, Anne M Murphy, Meral Gunay-Aygun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23239515      PMCID： PMC5004767          DOI： 10.1002/ajmg.a.35666

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN： 1552-4825            Impact factor:   2.802


× No keyword cloud information.
  2 in total

1.  Severe hypertrophic cardiomyopathy in Noonan syndrome-consider sequencing genes encoding sarcomeric proteins.

Authors:  Kim L McBride
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

2.  A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.

Authors:  Jill A Fahrner; Aisha Frazier; Suha Bachir; Michael F Walsh; Carolyn D Applegate; Reid Thompson; Marc K Halushka; Anne M Murphy; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2012-05-14       Impact factor: 2.802
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.